Posted on April 30th, 2016 No comments
Service Review: Take Home Naloxone programme in NI Consultation with service users and service providersPosted on April 1st, 2016 No comments
The aim of this evaluation was to establish whether the current model of naloxone provision and training across all Health and Social Care (HSC) Trusts in Northern Ireland is sufficient and to identify areas for development.
This report was prepared for the PHA. Please cite as:
Shorter, G.W. & Bingham, T. (2016). Service Review: Take Home Naloxone programme in NI. Consultation with service users and service providers. Belfast: Public Health Agency.
Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015Posted on October 9th, 2015 No comments
In February 2015, the Department of Public Health (DPH), Health Service Executive (HSE) in Dublin, Ireland, identified an unexpected increase in cases of acute HIV infection among people who inject drugs (PWID); three cases were diagnosed p24 antigen-positive in January and February 2015, compared with two cases diagnosed during the whole year in 2014 . Drug treatment clinicians had also identified increased use of a new psychoactive substance (NPS) alpha-pyrrolidinovalerophenone (?-PVP), known as snow blow, which was being used by ‘chaotic’ PWID, and which they suspected might be linked to the increase . Clinicians defined the chaotic group as homeless PWID who, if on opioid substitution treatment (OST), required daily attendance at their treatment programme, due to continued use of a variety of other illicit substances in an intensive or chaotic way. We undertook an epidemiological investigation to identify the likely source of this increase.
Posted on September 11th, 2015 No comments
This report, which is based on data provided by countries for reporting on the Dublin Declaration, summarises key issues related to HIV and people who inject drugs (PWID) in Europe and Central Asia. It identifies priority options for action to improve the HIV response for this population.
Posted on August 31st, 2015 No comments
These two videos are of interviews with individuals who have been affected by Drug Overdose . The interviews are on the theme of Rethink and Remember
Posted on May 11th, 2015 No comments
This publication describes general fundamental elements of nutrition and training required for safe and effective muscle building. By putting this advice into practice and adhering to a personal training and nutritional plan for a sustained length of time the desired result should be seen.
Posted on April 13th, 2015 No comments
A report in the Irish Examiner highlights a nationwide surge in the abuse of benzodiazepines and cannabis — and the spread of heroin outside Dublin — has driven drug treatment figures upwards over the last five years.
The Government has been accused of adopting a “head in the sand” approach to the problem and criticised for a continuing delay in introducing laws controlling the supply and possession of legal tranquillisers.
Garda sources said that organised crime gangs have moved in to control the supply of the lucrative trade in benzodiazepines (tranquillisers) and so-called z-drugs (hypnotics), while health researchers report that a third of all overdoses involve benzodiazepines.
Official statistics show a rise of almost 25% in the total number of people treated for illegal drug use between 2009 and 2013, increasing from 6,668 to 8,259.
Figures gathered by the Health Research Board for the main drug of abuse-level users show that the biggest increases are for benzodiazepines (up 175%, from 261 in 2009 to 719 in 2013), and cannabis (up 61%, from 1,531 to 2,460).
Opiates — in most cases heroin — rose by 4% from 4,013 to 4,189, but this reflected a fall in Dublin (from 2,360 to 2,100) and a 26% rise outside Dublin (from 1,653 to 2,089).
Request for Expressions of Interest: to carry out an Evaluation of the HSE Naloxone Demonstration ProjectPosted on April 2nd, 2015 No comments
The HSE has a stated commitment to take actions which focus on reducing the number of drug-related deaths and near-fatal drug poisonings. The HSE is currently finalising a Naloxone Demonstration Project, the purpose of which is to have Naloxone available for use by opioid users in order to prevent overdose. This project meets one of the key actions contained in the Primary Care Division Operational Plan 2015, “Implement a Naloxone Demonstration Project to assess and evaluate its suitability and impact (in line with NDS Action 40).”
The demonstration project involves 600 patients receiving take-home Naloxone within the current legislative framework. The product (Prenoxad 1mg/ml injection) is a licensed injectable administered via the parenteral route and formulated in a specific overdose pack. This allows for lay administration. The product is currently available inWales and England.
A key element of the demonstration project is the provision of training for drug users and those close to them, on the use of Naloxone and on recognising and dealing with overdose events.
Posted on January 14th, 2015 No comments
Posted on December 19th, 2014 No comments